The Government of Cameroon and its partners have made major investments in the last decade in prevention, treatment, and care of HIV-infected patients. However, unmet need for antiretroviral therapy (ART) among HIV-positive pregnant women remains high at 66%. Critical to satisfying this need is ensuring adequate availability of prevention of mother-to-child transmission (PMTCT) commodities for … Read more
A middle-income country in Central Africa, Cameroon had an HIV prevalence of 4.3% in 2011 in the general population 15–49 years of age (2011 DHS). The number of HIV patients on antiretroviral treatment (ART) has grown from a few hundred in 2001 to 78,000 at the end of 2009 and to 131,531 at the end … Read more
HIV, malaria, and unintended fertility constitute barriers to the achievement of Millennium Development Goals 4, 5, and 6 in Cameroon. The national health sector strategy 2011-2015 describes disease control targets, including the elimination of mother-to-child HIV transmission and reducing child mortality. In this analysis, SIAPS provides evidence for the design of interventions to strengthen the health supply system—a crucial … Read more
In Cameroon, the needs for antiretrovirals (ARVs) and other HIV commodities on a national scale have increased significantly over the years with the increase in the number of HIV-positive people registering for treatment. Financial partners such as the World Bank, the French Development Agency (Agence Française de Développement; AFD), and PEPFAR have committed their support alongside technical … Read more
